欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子抑制剂 > Others > Nedisertib

浏览历史

S89255

Nedisertib

源叶(MedMol) 98%
  • 英文名:
  • Nedisertib
  • 别名:
  • (S)-(2-chloro-4-fluoro-5-(7-morpholinoquinazolin-4-yl)phenyl)(6-methoxypyridazin-3-yl)methanol;MSC2490484A; MSC-2490484A; MSC 2490484A; M3814; M-3814; M 3814; nedisertib; peposertib
  • CAS号:
  • 1637542-33-6
  • 分子式:
  • C24H21ClFN5O3
  • 分子量:
  • 481.9066432
  • 核磁/质谱:
品牌货号产品规格价格(RMB) 库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
源叶(MedMol) S89255-5mg 98% ¥1040.00元 2 - - - EA 加入购物车
源叶(MedMol) S89255-10mg 98% ¥1600.00元 3 - - - EA 加入购物车
源叶(MedMol) S89255-25mg 98% ¥3200.00元 7 - - - EA 加入购物车
源叶(MedMol) S89255-100mg 98% ¥9600.00元 2 - - - EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献

质检证书(COA)

摩尔浓度计算器

相关产品

  • 产品描述: Nedisertib (M3814, Peposertib, MSC2490484A) 是一种口服可利用的、高效且选择性的 DNA activated protein kinase (DNA-PK) 的抑制剂,其IC50值小于3 nM
  • 靶点: DNA-PK(Cell-free assay):3 nM
  • 体外研究:
    M3814 potently inhibits DNA-PK catalytic activity and sensitizes multiple cancer cell lines to ionizing radiation (IR) and DSB-inducing agents. Inhibition of DNA-PK autophosphorylation in cancer cells leads to an increased number of persistent DSBs
  • 体内研究:
    Inhibition of DNA-PK autophosphorylation in xenograft tumors leads to an increased number of persistent DSBs. Oral administration of M3814 to two xenograft models of human cancer, using a clinically established 6-week fractionated radiation schedule, strongly potentiates the antitumor activity of IR and lead to complete tumor regression at nontoxic doses
  • 细胞实验: Cell lines: 92 cancer cell lines and resting peripheral blood mononuclear cells (PBMCs) Concentrations: 5 μmol/L–5 nmol/L Incubation Time: 120 h Method: Radiosensitization of 92 cancer cell lines and resting peripheral blood mononuclear cells (PBMCs) by M3814 is performed at Oncolead. Cell viability is determined with 3 Gy IR, M3814 (5 μmol/L–5 nmol/L), and a combination of 3 Gy IR and M3814 (5 μmol/L–5 nmol/L). Treated cells are incubated for 120 hours, fixed, stained with sulforhodamine B, and quantified colorimetrically.
  • 动物实验: Animal Models: 7- to 9-week-old female NMRI (nu/nu) mice Dosages: 5 mg/kg, 25 mg/kg, 100 mg/kg Administration: Oral gavage
  • 参考文献:
    1. Thomas Fuchss, et al. WO2014183850A1. 2. Frank T Zenke, et al. Pharmacologic Inhibitor of DNA-PK, M3814, Potentiates Radiotherapy and Regresses Human Tumors in Mouse Models. Mol Cancer Ther. 2020 May;19(5):1091-1101.
  • 溶解性: Soluble  in  DMSO、Ethanol
  • 保存条件: 2-8℃
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 2.075 ml 10.375 ml 20.751 ml
    5 mM 0.415 ml 2.075 ml 4.15 ml
    10 mM 0.208 ml 1.038 ml 2.075 ml
    50 mM 0.042 ml 0.208 ml 0.415 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。